Zercepac® plus capecitabine for intracranial lesions in a patient with HER2-positive converted from triple-negative breast cancer.

IF 4.7 4区医学 0 MEDICINE, GENERAL & INTERNAL

Minerva medica Pub Date : 2025-08-01 Epub Date: 2022-07-05 DOI:10.23736/S0026-4806.22.08240-4

Gang Li, Xuelian Li, Mei Yang

引用次数: 0

查看原文本刊更多论文

Zercepac®加卡培他滨治疗一名HER2阳性三阴性乳腺癌患者的颅内病变。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Minerva medica 医学-医学：内科

CiteScore

6.40

自引率

6.40%

发文量

358

审稿时长

>12 weeks

期刊介绍： Minerva Medica publishes scientific papers on internal medicine. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, special articles, letters to the Editor and guidelines. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work. Duties and responsibilities of all the subjects involved in the editorial process are summarized at Publication ethics.